Capstone Holding Corp.
CAPS | NASDAQ
$0.40
$0.00 (-0.94%)
Nov 2, 2026, 11:19 AM ET · Market open
-0.94%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $2.18M
1D Range
0.38 0.50
52W Range
0.38 3.29
Valuation (TTM)
PE -0.13
PB 0.23
EV/EBITDA -1.97
Valuation (NTM)
Forward PE N/A
Forward PEG N/A
Price Target N/A
Cash Flow
FCF Yield -157.4%
SBC Adj. FCF Yield -157.4%
SBC Impact N/A
Margins
Gross Margin 23.0%
Operating Margin -23.4%
FCF Margin -9.7%
Growth (CAGR)
Revenue 3Y | 5Y -8.7% |
0.6%
Dil EPS 3Y | 5Y -42.7% |
-20.8%
FCF 3Y | 5Y -16.0% |
-161.9%
Returns
ROA -77.3%
ROE -94.5%
ROIC -25.4%
Financial Health
Net Debt
$18.78M
Current Ratio 1.00
Interest Coverage 2.83
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mime...
Sector Basic Materials
Industry Construction Materials
Employees 36
IPO Date Jan 28, 1993
Website capstoneholdingcorp.com
Fiscal Year n/a
Latest News
No news articles available yet.
Earnings
Latest Earnings
Apr 7, 2026
EPS
-$0.13
Beat 0.00%
YoY:
+98.14% REV
$12.51M
Beat 0.00%
YoY:
+21.33%Add to Watchlist
Select watchlists to add or remove CAPS